Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Role of Micrornas in the Regulation of Insulin Signaling Pathway With Respect to Metabolic and Mitogenic Cascades: A Review Publisher Pubmed



Ebrahimi R1, 2 ; Bahiraee A3 ; Niazpour F1 ; Emamgholipour S1 ; Meshkani R1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Clinical Biochemistry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Students’ Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Medical Genetics, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran

Source: Journal of Cellular Biochemistry Published:2019


Abstract

Insulin resistance (IR) is a shared pathological condition among type 2 diabetes, obesity, cardiovascular disease, and other metabolic disorders. It is growing significantly all over the world and consequently, a substantial effort is needed for developing the potential novel diagnostics and therapeutics. An insulin signaling pathway is tightly modulated by different mechanisms including the epigenetic modifications. Today, a deal of great attention has been shifted towards the regulatory role of noncoding RNAs on target proteins of the insulin signaling pathway. Noncoding RNAs are a major area of the epigenetics which control gene expression at the posttranscriptional levels and include a large class of microRNAs (miRNAs). With this in view, many studies have implicated the mediatory effects of miRNAs on the downstream metabolic and mitogenic proteins of the insulin signaling pathway. Since providing new biomarkers for the early diagnosis of IR and related metabolic traits are very significant, we intended to review the possible role of miRNAs in the regulation of the insulin signaling pathway, with a primary focus on the downstream target proteins of the metabolic and mitogenic cascades. © 2019 Wiley Periodicals, Inc.
Other Related Docs
10. Micrornas As the Actors in the Atherosclerosis Scenario, Journal of Physiology and Biochemistry (2020)
11. Ctrp1 in Liver Disease, Advances in Clinical Chemistry (2017)
13. Nanoformulations of Natural Products for Management of Metabolic Syndrome, International Journal of Nanomedicine (2019)
14. Sirna and Epigenetic Aberrations in Ovarian Cancer, Journal of Cancer Research and Therapeutics (2016)
15. Methylation in Colorectal Cancer, Epigenetics Territory and Cancer (2015)
18. Association of Lin-28A Rs3811464 Variant With Susceptibility to Type 2 Diabetes, Journal of Clinical and Diagnostic Research (2017)
21. Insulin Signaling Pathway Model in Adipocyte Cells, Current Pharmaceutical Design (2023)
23. The Role of Dna Methylation in Cancer, Cancer Immunology: A Translational Medicine Context# Second Edition (2020)
26. Pharmacoepigenetics of Immunological Disorders, Pharmacoepigenetics (2019)